Michelle Romero, LCSW’s Post

In this special “Lunch and Learn” session of Cheat Codes, organized by the Agios Diversity Council, Dr. Simone Eastman Uwan M.D. shares her inspiring journey living with and advocating for #sicklecell disease. Dr. Uwan discusses her background, achievements in medicine and advocacy, and personal experiences with misdiagnosis and the challenges shares with many other sickle cell patients. Highlighting critical insights from her books, she emphasizes the importance of medical management, patient empowerment, and diverse treatment options in fighting this disease. Tune in here: https://lnkd.in/epP7_uhP Cheat Codes is a podcast about sickle cell disease and is intended for patients, caregivers, providers, and the greater community of people who are impacted by it. Each episode of Cheat Codes: A Sickle Cell Podcast strives to provide listeners with critical education, the latest scientific updates, and voices from the sickle cell community. Cheat Codes: A Sickle Cell Podcast is sponsored by Agios Pharmaceuticals Inc. Visit Agios.com to learn more. This podcast is intended for informational and educational purposes only and is not intended as medical advice. Please speak with your healthcare professional before making any treatment decisions. Listen, rate, review, and subscribe wherever you get your podcasts! #SickleCellAwareness #SickleCellAwarenessMonth

Understanding the safety, efficacy, and cost-saving potential of biosimilars is imperative for both pharmacy students and patients. Yet patients and consumers do not know much about biosimilars. Through the Script Your Future campaign, Senior Director of Health Policy Robin Strongin was joined by representatives from the FDA and Biosimilars Forum on this episode of the We Can Do This podcast, where they review what consumers should know about biosimilars and what it means for them. Listen here: https://lnkd.in/dsVA9S5B

💫 Stay updated with vital content from our Heart Failure Management Hub: https://ow.ly/2CuC50SMn47 Browse a wide variety of videos, podcast episodes, CME-accredited courses and content from the latest congresses. Why check out this content? 🫀Key heart failure education, all in one place 📊 Stay ahead with the latest clinical data 📚 In-depth review on complex patient cases 🩺 HFpEF diagnosis and stratification insights Supported by an unrestricted educational grant from AstraZeneca

Antibiotics versus placebo in adults with CT-confirmed uncomplicated acute appendicitis (APPAC III) webop, the multimedia surgical learning hub on the internet, would like to share a randomised controlled and double-blinded clinical trial from 2022 with you in this podcast. The APPAC-III-Trial is about the treatment of uncomplicated appendicitis with an antibiotic combination compared to a placebo.

The #PsA podcast for April has now arrived! Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the 2023 update to the #EULAR recommendations for the treatment of PsA and the improvement of #PROs with #deucravacitinib therapy in a recent Phase 2 trial. Watch their full discussion to stay at the forefront of PsA treatment and inform choices in your clinical practice today: https://lnkd.in/eRz9z-cE

The first episode of a New Scientist podcast series, “Transforming Clinical Trials”, features James O'Shaughnessy ,chair of the independent review of UK commercial clinical trials. In the episode, Lord O'Shaughnessy discusses the UK's unique advantages for conducting clinical trials, including its cutting-edge genomics, data analytics, and technology integration. He also highlights the NHS diverse patient population and healthcare system, making it an ideal environment for large-scale and commercially sponsored trials. The podcast sheds light on why commercial clinical trials are crucial and explores how the UK's commitment to embracing decentralised trials and leveraging technology ensures more inclusive and efficient research. Great episode, look forward to the next! Find it here 👇🏼👇🏼👇🏼👇🏼👇🏼 https://lnkd.in/eNrSRUJa #ClinicalTrials #UKHealthcare #NHS #HealthcareTechnology #R&D #lifesciences #PatientTreatment #NewMedicines #Genomics #DataAnalytics

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the platform business model and its use in the healthcare industry to drive innovation and reimagine how care is provided.

Interested in the hot topic of patient-centric publications? Our colleague and #PatientEngagement expert, Adeline Rosenberg, has guest hosted a new ISMPP (International Society for Medical Publication Professionals) InformED podcast all about delivering patient-centric publications. In the episode, Adeline chats with Trishna Bharadia, BA(hons), MFPM(Hon) (The Spark Global) and Gavin Jones (OPEN Health) who consider big questions like: - Why is there a need for patient-centric publications? - How can we make publications more patient-centric? - How do we involve patients in publications? - What does the future look like for patient involvement in publications? Listen here! #ISMPP #PatientInvolvement #PatientAdvocacy https://lnkd.in/eKqNf3wX

Episode 9 of our Trail Blazers series is now live! 📽   On this episode we chat to Elena Mills about her journey with The Salve and the transformative power of embracing the B-Corp framework. Join us as we dive into the pharmaceutical landscape with Johnny and Elena, discussing the urgent need for investment in horizon scanning, especially concerning neglected diseases. You can catch the full episode here: https://lnkd.in/e_99JdzV #trailblazers #medicalpodcast #podcast #bcorp #pharmaceuticallandscape

FeNO testing and spirometry can make a valuable pairing in asthma care. In our latest podcast episode, we’re looking at how these two pieces of the respiratory puzzle can help to complete the picture. Listen today: https://lnkd.in/euzVHw-P